Gilead Sciences Inc
DUS:GIS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Gilead Sciences Inc
DUS:GIS
|
US |
|
Amgen Inc
NASDAQ:AMGN
|
US |
|
China Shanshui Cement Group Ltd
HKEX:691
|
CN |
|
A
|
ASML Holding NV
DUS:ASME
|
NL |
|
Cherry SE
F:C3RY
|
DE |
|
H
|
Hoya Corp
OTC:HOCPY
|
JP |
|
Sumitomo Densetsu Co Ltd
TSE:1949
|
JP |
|
Siemens AG
F:SIEB
|
DE |
|
Fomento Economico Mexicano SAB de CV
NYSE:FMX
|
MX |
Wall St Price Targets
GIS Price Targets Summary
Gilead Sciences Inc
According to Wall Street analysts, the average 1-year price target for GIS is 138.13 EUR with a low forecast of 105.93 EUR and a high forecast of 161.15 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GIS's stock price target?
Price Target
138.13
EUR
According to Wall Street analysts, the average 1-year price target for GIS is 138.13 EUR with a low forecast of 105.93 EUR and a high forecast of 161.15 EUR.
What is the Revenue forecast for Gilead Sciences Inc?
Projected CAGR
4%
Over the last 14 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 4%.
What is the Operating Income forecast for Gilead Sciences Inc?
Projected CAGR
9%
Over the last 14 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 8 years is 9%.
What is the Net Income forecast for Gilead Sciences Inc?
Projected CAGR
10%
Over the last 14 years, the compound annual growth rate for Net Income has been 8%. The projected CAGR for the next 8 years is 10%.
